Dynavax Technologies Corp...

NASDAQ: DVAX · Real-Time Price · USD
10.62
-0.20 (-1.85%)
At close: Aug 14, 2025, 3:59 PM
10.45
-1.60%
After-hours: Aug 14, 2025, 07:34 PM EDT

Dynavax Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
277.25M 232.28M 722.68M 439.44M
Cost of Revenue
49.45M 50.17M 262.15M 173.57M
Gross Profit
227.8M 182.12M 460.53M 265.87M
Operating Income
-4.12M -37.03M 283.52M 134.49M
Interest Income
36.46M 31.99M 7.91M 140K
Pretax Income
30.86M -4.37M 294.3M 77.52M
Net Income
27.31M -6.39M 293.16M 76.71M
Selling & General & Admin
170.37M 152.95M 131.41M 100.16M
Research & Development
61.55M 54.89M 46.6M 32.23M
Other Expenses
n/a 11.31M n/a n/a
Operating Expenses
231.92M 219.15M 178.01M 132.38M
Interest Expense
6.79M 6.76M 6.73M 11.18M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
281.37M 269.31M 440.16M 305.96M
Income Tax Expense
3.55M 2.02M 1.14M 808K
Shares Outstanding (Basic)
130.05M 128.73M 126.4M 116.26M
Shares Outstanding (Diluted)
133.34M 128.73M 150.8M 133.01M
EPS (Basic)
0.21 -0.05 2.32 0.62
EPS (Diluted)
0.20 -0.05 1.97 0.57
EBITDA
45.7M 9.67M 307.7M 95.71M
EBIT
37.65M 2.39M 301.03M 88.7M
Depreciation & Amortization
8.05M 7.28M 6.67M 7.01M